The NAGA Group AG

  • WKN: A161NR
  • ISIN: DE000A161NR7
  • Land: Deutschland

Nachricht vom 16.09.2021 | 20:36

The NAGA Group AG: NAGA RESOLVES ON CAPITAL INCREASE WITH GROSS PROCEEDS OF EUR 22.7 MILLION

The NAGA Group AG / Key word(s): Corporate Action
The NAGA Group AG: NAGA RESOLVES ON CAPITAL INCREASE WITH GROSS PROCEEDS OF EUR 22.7 MILLION

16-Sep-2021 / 20:36 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


NAGA RESOLVES ON CAPITAL INCREASE WITH GROSS PROCEEDS OF EUR 22.7 MILLION


Hamburg, September 16, 2021

The Management Board of The Naga Group AG (ISIN DE000A161NR7, Frankfurt Stock Exchange Scale segment), with approval of the Supervisory Board, resolved today to increase the Company's share capital by way of an exercise of the authorized capital under exclusion of shareholders' subscription rights by EUR 4,204,990.00 by issuing 4,204,990 new ordinary registered shares with no-par value (Stückaktien), each with a notional value of EUR 1.00, against cash contributions (the "New Shares").

The shares will be placed in a private placement at a placement price of EUR 5.40. The Company has already received non binding commitments for all New Shares.

The Company intends to use the net proceeds from the Capital Increase to accelerate its marketing and growth activities and expand international growth through key hires.

Disclaimer
This announcement is not intended for direct or indirect publication or distribution within or into the United States of America ("United States"). This announcement does not constitute an offer of securities for sale in the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended ("Securities Act"), and may not be sold or offered for sale in the United States absent registration under the Securities Act. There will be no public offering of securities in the United States.

Contact:
The NAGA Group AG
Andreas Luecke, Vorstand
Hohe Bleichen 12
20354 Hamburg
E: press@naga.com


16-Sep-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

Aktuelle Research-Studie

Original-Research: Gold Mountain Mining Corp. (von hanseatic stock publishing UG (haftungsbeschränkt)): Gold Mountain Mining Corp.

29. November 2021